Japanese Encephalitis Vaccine

Kathryn Dzintars, Pharm.D. BCPS, Noreen A. Hynes, M.D., M.P.H., D.T.M.&H.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.
Japanese Encephalitis Vaccine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

  1. Inactivated SA-14 virus strain: grown in Vero cells (IXIARO).
    1. The only licensed vaccine in the U.S. Indicated in the U.S. for all persons > 2 months of age.
    2. The same vaccine is sold in other countries as JESPECT.
  2. In some other countries, a live, attenuated SA-14 strain vaccine is available.
  3. The previously available (Biken) vaccine grown in mouse-brain is only available in Japan.

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

  1. Inactivated SA-14 virus strain: grown in Vero cells (IXIARO).
    1. The only licensed vaccine in the U.S. Indicated in the U.S. for all persons > 2 months of age.
    2. The same vaccine is sold in other countries as JESPECT.
  2. In some other countries, a live, attenuated SA-14 strain vaccine is available.
  3. The previously available (Biken) vaccine grown in mouse-brain is only available in Japan.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: July 3, 2020